Comprehensive multi-omics pan-cancer analysis revealed that ANTXR1 is a potential biomarker for diagnosis and immunotherapy

Yue Qiu, Zhu Yu, Weikun Lai, Wenqian Xu, Jian Yang, Sijiang Zhou, Junqiang Chen · 2026

Read Comprehensive multi-omics pan-cancer analysis revealed that ANTXR1 is a potential biomarker for diagnosis and immunotherapy by Yue Qiu, Zhu Yu, Weikun Lai, Wenqian Xu, Jian Yang, Sijiang Zhou, Junqiang Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471474.txt.

Description

Qiu and colleagues ran a pan-cancer scan of ANTXR1, a cell-surface receptor first known for letting anthrax toxin into cells, asking whether it flags tumors and shapes immunity. Their 2026 analysis combined cancer genome databases covering 10,967 tumors from 10,593 patients with single-cell data and follow-up laboratory tests in gastric cancer.

ANTXR1 ran abnormally high in many tumor types and tracked with later stage and worse survival, especially in gastric cancer. High levels also matched heavy M2 macrophage infiltration, immune cells that shield tumors, alongside reduced numbers of cancer-killing CD8 T cells. Single-cell mapping pinned most ANTXR1 production on fibroblasts, the scaffolding cells inside tumors. Knocking the gene down in gastric cancer cells weakened their growth in laboratory and animal models.

Catalog record

CREATORYue Qiu, Zhu Yu, Weikun Lai, Wenqian Xu, Jian Yang, Sijiang Zhou, Junqiang Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13471474

Browse the full library · About the Tower of Babel